Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

ROSEN, A TOP RANKED LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA

February 06, 2024

WHY: NEW YORK, NY - (NewMediaWire) - February 06, 2024 - Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of...

Via NewMediaWire

Topics Lawsuit

ROSEN, A TOP RANKED LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA

February 06, 2024

WHY: NEW YORK, NY - (NewMediaWire) - February 06, 2024 - Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of...

Via TheNewswire.com

Topics Lawsuit

Is There Any Hope for Cassava Sciences Stock? ↗

February 03, 2024

Battered by controversy, this company will need to show real results to prosper.

These small-cap biotech stocks feature large addressable markets combined with positive analyst sentiment and potential breakthroughs in 2024.

(SAVA) - Analyzing Cassava Sciences's Short Interest ↗

January 29, 2024

Via Benzinga

3 small-cap biotechs with potential breakthroughs in 2024

February 06, 2024

Via MarketBeat

Topics Bankruptcy

Cassava ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Cassava Sciences, Inc. and Encourages Investors to Contact the Firm

February 05, 2024

From Bragar Eagel & Squire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SAVA

February 05, 2024

From The Rosen Law Firm, P.A.

Via Business Wire

SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

February 05, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

3 Biotech Stocks to Sell in January Before They Crash and Burn ↗

January 25, 2024

The biotech industry is one of the most profitable though risky at the same time. Here are three biotech stocks to sell.

Cassava Sciences sees its Relative Strength Rating move into the elite 90-plus level.

Cassava Sciences Stock Continues Showing Rising Relative Strength ↗

January 16, 2024

Via Investor's Business Daily

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 15, 2024

Via Benzinga

Portfolio Protection: 7 Risky Stocks to Drop Right Now ↗

January 12, 2024

Ahead of further or unforeseen challenges, if you own any of these seven risky stocks, now's the time to bail.

Following a distribution, investors in Cassava Sciences and SAVA stock now have some warrants to factor into their models today.

New SAVAW Warrants Are Trading After Cassava Sciences’ Distribution ↗

January 05, 2024

Cassava Sciences Completes Dividend Distribution of Warrants to Shareholders

January 05, 2024

Wall Street analysts foresee up to 316% upside in three fast-paced companies in the new year.

3 Growth Stocks Expected to Skyrocket in 2024, According to Wall Street ↗

December 26, 2023

Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

December 21, 2023

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.

Via Benzinga

Paychex Reports Downbeat Sales, Joins BlackBerry And Other Big Stocks Moving Lower On Thursday ↗

December 21, 2023

U.S. stocks traded higher, with the Dow Jones index gaining around 200 points on Thursday.

Via Benzinga

Topics Stocks

Why Cassava Sciences Stock Zoomed 21% Higher This Week ↗

December 15, 2023

The company has chosen an offbeat way to keep its investors sweet.

Cassava Sciences sees its Relative Strength Rating reach the 80-plus level.

Cassava Sciences Stock Shows Rising Relative Strength Following 3 Up Days ↗

December 13, 2023

Via Investor's Business Daily

Why Is Cassava Sciences (SAVA) Stock Up 15% Today? ↗

December 12, 2023

Although Cassava Sciences’ issuance of warrants presents risks, the underlying Phase 3 trial support boosted SAVA stock.

Blue Bird Posts Upbeat Results, Joins Oil-Dri Corporation of America, Eagle Bulk Shipping And Other Big Stocks Moving Higher On Tuesday ↗

December 12, 2023

U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Tuesday.

Via Benzinga

Topics Stocks

Cassava Sciences Announces Dividend Distribution of Warrants to Shareholders

December 12, 2023

Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading higher Monday on continued upward momentum. The stock has gained more than 20% over than last five days. What To Know:

What's Going On With Cassava Sciences Stock? ↗

December 11, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 11, 2023

Via Benzinga

High short interest stocks: this popular trend is re-emerging

December 11, 2023

Renewed optimism has led to higher risk tolerance in stocks, which has brought back a popular trend: Stocks with high short interest are gaining popularity

Via MarketBeat

Topics ETFs

Why Cassava Sciences Stock Soared Today ↗

December 08, 2023

Investors cheered the arrival of a trio of new board members.

Dr. Nicaise, Mr. Gravier and Mr. Anderson have years of experience in drug development, healthcare M&A and working with the U.S. Government

Cassava Sciences Appoints Three New Members to its Board of Directors

December 07, 2023

While most folks should stick on the established road, these stock picks for contrarian investors might tempt the intrepid.

7 High-Risk, High-Reward Stocks for the Extreme Contrarian ↗

November 14, 2023

Cassava Sciences Reports Third Quarter 2023 Financial and Operating Results

November 07, 2023